{"result": {"id": "chatcmpl-BU4GutjlgmMwDww0NU9udO50DKID6", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>PROTON BEAM THERAPY<|>EVENT<|>Proton Beam Therapy is a type of cancer treatment reimbursed under specific conditions when administered as an inpatient or outpatient procedure.)\n##\n(\"entity\"<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>EVENT<|>Cell Tissue and Gene Therapy Treatment is a reimbursable treatment for cancer that must meet specific regulatory guidelines and be deemed medically necessary.)\n##\n(\"entity\"<|>MOH<|>ORGANIZATION<|>The Ministry of Health (MOH) is the governing body that approves treatments like Proton Beam Therapy and Cell Tissue and Gene Therapy Treatment.)\n##\n(\"entity\"<|>HSA<|>ORGANIZATION<|>The Health Science Authority (HSA) is responsible for regulating health science practices and approving treatments in conjunction with the MOH.)\n##\n(\"entity\"<|>LIFE ASSURED<|>PERSON<|>The life assured is the individual covered under the insurance policy who undergoes the specified treatments.)\n##\n(\"entity\"<|>BENEFITS SCHEDULE<|>BENEFIT<|>The Benefits Schedule outlines the limits and conditions under which treatments like Proton Beam Therapy and Cell Tissue and Gene Therapy Treatment are reimbursed.)\n##\n(\"entity\"<|>DEDUCTIBLE<|>BENEFIT<|>The Deductible is the amount that the life assured must pay out-of-pocket before the insurance coverage kicks in for treatments.)\n##\n(\"entity\"<|>CO-INSURANCE<|>BENEFIT<|>Co-insurance is the percentage of costs that the life assured must pay after the deductible has been met for treatments.)\n##\n(\"entity\"<|>PRO-RATION<|>BENEFIT<|>Pro-ration refers to the adjustment of benefits based on specific conditions or limits set in the insurance policy.)\n##\n(\"relationship\"<|>LIFE ASSURED<|>PROTON BEAM THERAPY<|>The life assured is eligible for reimbursement for Proton Beam Therapy under the insurance policy<|>8)\n##\n(\"relationship\"<|>LIFE ASSURED<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>The life assured is eligible for reimbursement for Cell Tissue and Gene Therapy Treatment under the insurance policy<|>8)\n##\n(\"relationship\"<|>MOH<|>PROTON BEAM THERAPY<|>The Ministry of Health approves Proton Beam Therapy as a reimbursable treatment<|>7)\n##\n(\"relationship\"<|>MOH<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>The Ministry of Health approves Cell Tissue and Gene Therapy Treatment as a reimbursable treatment<|>7)\n##\n(\"relationship\"<|>HSA<|>CELL TISSUE AND GENE THERAPY TREATMENT<|>The Health Science Authority regulates and approves Cell Tissue and Gene Therapy Treatment<|>7)\n##\n(\"relationship\"<|>HSA<|>PROTON BEAM THERAPY<|>The Health Science Authority regulates and approves Proton Beam Therapy<|>7)\n##\n(\"relationship\"<|>BENEFITS SCHEDULE<|>LIFE ASSURED<|>The Benefits Schedule defines the coverage limits for the life assured's treatments<|>6)\n##\n(\"relationship\"<|>DEDUCTIBLE<|>LIFE ASSURED<|>The Deductible is a condition that affects the life assured's reimbursement for treatments<|>5)\n##\n(\"relationship\"<|>CO-INSURANCE<|>LIFE ASSURED<|>Co-insurance is a cost-sharing requirement that affects the life assured's reimbursement for treatments<|>5)\n##\n(\"relationship\"<|>PRO-RATION<|>LIFE ASSURED<|>Pro-ration affects the benefit limits available to the life assured for treatments<|>5)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": [], "audio": null, "function_call": null, "tool_calls": null}}], "created": 1746505960, "model": "gpt-4o-mini-2024-07-18", "object": "chat.completion", "service_tier": "default", "system_fingerprint": "fp_0392822090", "usage": {"completion_tokens": 825, "prompt_tokens": 2234, "total_tokens": 3059, "completion_tokens_details": {"accepted_prediction_tokens": 0, "audio_tokens": 0, "reasoning_tokens": 0, "rejected_prediction_tokens": 0}, "prompt_tokens_details": {"audio_tokens": 0, "cached_tokens": 1664}}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,benefit,date,event,location]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,benefit,date,event,location\nText: 6.8 What do we pay for Inpatient and Outpatient Proton Beam Therapy?\nWe reimburse for the Reasonable and Customary Expenses incurred, up to the limits as set out in the \nBenefits Schedule, when the life assured undergoes Proton Beam Therapy treatment as an Inpatient, \nday surgery or Outpatient procedure, treated by a Registered Medical Practitioner in a Hospital or \nMediSave/MediShield Life accredited cancer treatment centres. \nThis benefit is subject to the Deductible, Co-insurance and Pro-ration.\nWe will only cover proton beam therapy treatment if it is administered as an approved proton beam \ntherapy indication as stated on the MOH's website, as may be amended from time to time.\nWe will also reimburse consultation fees, diagnostic and laboratory tests if it is ordered by the \nRegistered Medical Practitioner before the life assured undergoes this treatment.\nWe will not pay for any pre- or post-hospitalisation expenses incurred in relation to Outpatient Proton \nBeam Therapy.\n1.4.6.9 What do we pay for Cell Tissue and Gene Therapy Treatment? \nWe reimburse the Reasonable and Customary Expenses incurred, up to the limits as set out in the \nBenefits Schedule, when the life assured undergoes Cell Tissue and Gene Therapy Treatment as an \nInpatient or day surgery procedure, as long as the following conditions are met:\n- the Cell Tissue and Gene Therapy Treatment must be approved by MOH and the Health Science \nAuthority (HSA) and should satisfy all other guidelines of the Cell Tissue and Gene Therapy \nTreatment regulations, as issued by MOH; and\n- the attending Registered Medical Practitioner must recommend in writing that the Cell Tissue and \nGene Therapy Treatment is Medically Necessary.\nThis benefit is subject to the Deductible, Co-insurance and Pro-ration.\nWhen we work out the benefit limit that we will pay for the Cell Tissue and Gene Therapy Treatment, \nwe add all Reasonable and Customary Expenses incurred for the treatment (including pre- and post\u0002hospitalisation treatment) under this benefit. \n1.4.6.10 What is the Refresh benefit? \nIf the life assured has exceeded the Policy Year Limit and is hospitalised subsequently for an Illness\nor Injury that is not directly or indirectly related to any existing or past Illnesses or Injuries within the \nsame Policy Year, we will reset the Policy Year Limit and any benefit sub\n######################\nOutput:", "role": "user"}], "parameters": {"model": "gpt-4o-mini", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}}